[O1] 末梢神経・筋①

[O1-04] Delandistrogene moxeparvovec投与後のDMD患者における急性肝障害の軽減と管理：エキスパートの見解

小牧 宏文¹, Shieh Perry², Diamond Tamir³, Chapin Catherine A.⁴, Ahmad Jawad⁵, Salama Alan⁶, Soslow Jonathan⁷, Veerapandiyan Aravindhan⁸, Gerber Marianne⁹, Asher Damon¹⁰ (1.国立精神・神経医療研究センタートランスレーショナル・メディカルセンター, 2.University of California Los Angeles, Los Angeles, CA, USA, 3.Children's Hospital of Philadelphia, Philadelphia, PA, USA, 4.Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA, 5.Mount Sinai, New York, NY, USA, 6.University College, London, UK, 7.Vanderbilt University Medical Center, Nashville, TN, USA, 8.Arkansas Children's Hospital, Little Rock, AR, USA, 9.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 10.Sarepta Therapeutics, Inc., Cambridge, MA, USA)

閲覧にはパスワードが必要です